Expand SGMT Menu
SGMT MENU

SGMT Latest Press Releases

-- June 29, 2026 --

Sagimet Biosciences Joins the Russell 2000 and Russell 3000 Indexes Globe Newswire 7:00 AM

-- June 22, 2026 --

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:49 PM

-- May 27, 2026 --

Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH Globe Newswire 7:00 AM

-- May 13, 2026 --

Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Globe Newswire 7:00 AM

-- May 12, 2026 --

Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates Globe Newswire 7:30 AM

-- May 11, 2026 --

Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago Globe Newswire 7:00 AM

-- April 27, 2026 --

Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock Globe Newswire 7:15 AM
Sagimet Biosciences Provides Strategic and Corporate Updates Globe Newswire 7:00 AM

-- April 20, 2026 --

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer Globe Newswire 7:00 AM

-- April 6, 2026 --

Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- March 11, 2026 --

Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates Globe Newswire 7:30 AM

-- February 25, 2026 --

Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences Globe Newswire 7:00 AM

-- February 5, 2026 --

Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes